Search Within

Manickam Janakiraman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (12)
Groups
  1. Department of Medicine (33)
  2. GSK Faculty (33)
  3. Genitourinary Oncology Service (33)
  4. Human Oncology and Pathogenesis Program (33)
  5. Solid Tumor Oncology Division (33)
  6. Department of Pathology and Laboratory Medicine (19)

More Groups

People
  1. David Solit (33)
  2. Adriana Heguy (13)
  3. Neal Rosen (12)
  4. Barry Taylor (11)
  5. Yogindra Persaud (11)
  6. Christine Pratilas (9)

More People

Years
  1. 2013 (1)
  2. 2012 (14)
  3. 2011 (7)
  4. 2010 (5)
  5. 2009 (4)
  6. 2008 (1)

More Years

Publications
  1. Cancer Research (12)
  2. Journal of Clinical Oncology (4)
  3. Laboratory Investigation (3)
  4. Modern Pathology (3)
  5. Nature (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. Nature Publishing Group (7)
  3. American Society of Clinical Oncology (4)
  4. Nature Research (3)
  5. American Association for the Advancement of Science (1)
  6. Elsevier Inc. (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of KRAS, NRAS, BRAF and PIK3CA mutations in matched primary and metastatic colorectal carcinomas
    Meeting Abstract

    Vakiani, E.; Janakiraman, M.; Shia, J.; Saltz, L.; Kemeny, N.; Weiser, M.; Solit, D.
    Laboratory Investigation (2011)

    Fulltext@MSK | Save
  • Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma
    Journal Article

    Al-Ahmadie, H. A.; Iyer, G.; Janakiraman, M.; Lin, O.; Heguy, A.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; Balar, A.; more...
    Journal of Pathology (2011)

    Fulltext@MSK | Save
  • Concurrent loss of PTEN and RB is sufficient to confer BRAF independence in melanomas harboring V600E BRAF mutations
    Meeting Abstract

    Xing, F.; Persaud, Y.; Pratilas, C.; Janakiraman, M.; She, Q. B.; Liu, C.; Dolgalev, I.; Heguy, A.; Wolchok, J.; Cobrinik, D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Genetic determinants of AKT-dependence in epithelial ovarian cancer
    Meeting Abstract

    Hanrahan, A. J.; Scarperi, S.; Sakr, R. A.; Westfal, M. L.; Godsell, J.; Janakiraman, M.; Levine, D. A.; She, Q. B.; Rosen, N.; Solit, D. B.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Acquired KRAS mutation as mechanism of resistance to EGFR inhibition in colorectal cancer
    Meeting Abstract

    Liska, D.; Janakiraman, M.; Chen, C. T.; Ding, P. R. ; Solit, D. B.; Weiser, M. R.
    Journal of the American College of Surgeons (2010)

    Fulltext@MSK | Save
  • Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies
    Journal Article

    Veeriah, S.; Taylor, B. S.; Meng, S.; Fang, F.; Yilmaz, E.; Vivanco, I.; Janakiraman, M.; Schultz, N.; Hanrahan, A. J.; Pao, W.; more...
    Nature Genetics (2010)

    Fulltext@MSK | Save
  • Genomic and biological characterization of exon 4 KRAS mutations in human cancer
    Journal Article

    Janakiraman, M.; Vakiani, E.; Zeng, Z.; Pratilas, C. A.; Taylor, B. S.; Chitale, D.; Halilovic, E.; Wilson, M.; Huberman, K.; Ricarte-Filho, J. C.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Genetic predictors of MEK dependence in V600E BRAF mutant melanoma
    Meeting Abstract

    Xing, F.; Pratilas, C.; Persaud, Y.; Janakiraman, M.; Houghton, A.; Rosen, N.; Solit, D.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Identification and biological characterization of exon 4 KRAS mutations by MALDI-TOF Mass Spectrometry based genotyping
    Meeting Abstract

    Janakiraman, M.; Zeng, Z.; Chitale, D.; Halilovic, E.; Rosen, N.; Vakiani, E.; Heguy, A.; Ladanyi, M.; Jhanwar, S.; Saltz, L.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Amplification of wild-type BRAF in melanoma is associated with activation of RAF-MEK-ERK signaling and MEK-dependence
    Meeting Abstract

    Blumenthal, E.; Poulikakos, P. I.; Tadi, M.; Grbovic-Huezo, O.; Taylor, B. S.; Janakiraman, M.; Leversha, M.; Viale, A.; Solit, D. B.; Rosen, N.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save